Log In
BCIQ
Print this Print this
 

SXN101959

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
DescriptionTargeted secretion inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationAcromegaly
Indication DetailsTreat acromegaly
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today